Navigation Links
Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
Date:5/28/2008

ly great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing.

ABthrax(TM) (raxibacumab) is in late-stage development for the treatment of inhalation anthrax, and the Company is on track to begin the delivery in fall 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. Other HGS drugs in clinical development include two TRAIL receptor antibodies for the treatment of cancer. The initiation of dosing is imminent in a Phase 1 trial of HGS1029, a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins, in patients with advanced solid tumors. In addition, HGS has substantial financial rights to three products in the GlaxoSmithKline clinical development pipeline.

For more information about HGS, please visit the Company's web site at http://www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinical_trials@hgsi.com or by calling HGS at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

SAFE HARBOR STATEMENT

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent,
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
2. St. Jude Finds Dancing Hair Cells Are Key to Humans Acute Hearing
3. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
4. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
5. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
6. First Human Implant of New Archus Orthopedics Facet Replacement System
7. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
8. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
9. Data Show SuperGens MP-470 is Safe in Humans
10. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
11. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013   Direct to ... mastectomy is an appropriate option for many women ... surgically reduce their breast cancer risk, or with ... expansion process and a second surgery to insert ... the same surgery as mastectomy can be a ...
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... , May 23, 2013  Datameer announced ... to enable data discovery on their big data ... self-service tools they need to quickly and easily ... A Fortune 19 company, Cardinal Health ... companies. It provides pharmaceuticals and medical products to ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2Cardinal Health Selects Datameer for Healthcare Data Discovery 2
(Date:5/23/2013)... May 23 (HealthDay News) -- Schools should ensure ... physical activity each day to support their health ... new report. Although previous studies show ... promotes health and development, it,s estimated that only ... meeting this recommendation, according to the report from ...
(Date:5/23/2013)... -- Symptoms of borderline personality disorder often mimic ... treatment. But researchers in Canada say they have ... borderline personality disorder: a tendency to misinterpret emotions ... difficulty processing facial emotions and will see a ... Ruocco, a clinical neuropsychologist and assistant professor at ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... badly as methamphetamine or crack cocaine, a new study ... mouth, or ,coke mouth, it is startling to see ... the same," said Dr. Mohamed Bassiouny, a professor of ... in Philadelphia. Methamphetamine, crack cocaine and soda -- ...
(Date:5/23/2013)... Although a study in 2012 suggested a cancer ... associated with Alzheimer,s disease, three groups of researchers ... those findings. The teams said their research ... the drug involved in the study, bexarotene (Targretin), ... abnormalities, pancreatitis, headaches, fatigue, weight gain, depression, nausea, ...
(Date:5/23/2013)... shown that an immune regulatory molecule called IL-21 is ... infections. , The results are published in the ... IL-21 could be important in the development of antiviral ... the first author of the paper. The senior author ... Center and a Georgia Research Alliance Eminent Scholar. , ...
Breaking Medicine News(10 mins):Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2
... Fox Chase Cancer Center and Geisinger Health System ... the translation of medical and health-related discoveries into ... part of the agreement, the three institutions will ... at Temple, to design and implement research on ...
... NEW YORK, Aug. 12 Care Investment Trust Inc.,(NYSE: ... finance company,investing in healthcare-related real estate and commercial mortgage ... manager, CIT,Healthcare that includes the following terms:, -- ... to purchase up,to $125 million of mortgage assets on ...
... to Increase Breast and ... Cervical Cancer Screening Rates, COLUMBIA, Md., ... guidance company, today announced the,launch of their Women,s Health and ... help increase the,prevention and early detection of breast and cervical ...
... Volume, but Lower Eyelids Get Fatter with Age, Study Finds , ... This study examined why lower eyelids get bulgy with age by ... (12 29 years old, 30 54, and 55 ... plastic surgeons discovered that while the rest of the face loses ...
... Precisely targeted radiation therapy can eradicate all evidence of ... to only a few sites, suggests the first published ... August 15, 2008, issue of Clinical Cancer Research, ... of Chicago Medical Center report that targeted radiation therapy ...
... (OTC Bulletin Board: DSKA) ("Duska") announced today that it ... (the "FDA"),Division of Cardiovascular and Renal Products on a ... lead drug, ATPace(TM), for the acute,treatment of a frequent ... 16, 2008, Duska met with the FDA and confirmed ...
Cached Medicine News:Health News:Temple, Fox Chase and Geisinger create Keystone Institute for Translational Medicine 2Health News:Care Investment Trust Inc. Announces an Agreement in Principle for CIT Healthcare to Purchase Mortgage Assets and Reduce Management Fee 2Health News:Resolution Health Introduces Women's Health and Wellness Action Campaign 2Health News:Resolution Health Introduces Women's Health and Wellness Action Campaign 3Health News:Resolution Health Introduces Women's Health and Wellness Action Campaign 4Health News:News briefs from the American Society of Plastic Surgery 2Health News:Targeted radiation therapy can control limited cancer spread 2Health News:Targeted radiation therapy can control limited cancer spread 3Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 2Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 3Health News:Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis 4
Solid 14 mm blades. Dull finish....
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model....
Open wire style blades allow complete manipulation of the phaco tip inside the eye. Lid control is excellent, exposure is maximized, and the likelihood of positive pressure is reduced....
Medicine Products: